20110704
 Health & Wellness: New Blood-Thinner Receives FDA Approval   By Loftus, Peter, The Wall Street Journal,  Jul 5, 2011  The U.S. Food and Drug Administration approved a new drug to prevent blood clots that was co-developed by Johnson & Johnson and Bayer AG. The clearance of the anticoagulant Xarelto is the latest development in an emerging battle among major drug companies, including Pfizer Inc., over what is expected to become a multibillion-dollar market for new blood thinners treating cardiovascular conditions, which may replace older drugs, including warfarin.   
